There is increasing interest in the nature of the emotion recognition deficit in Huntington's disease (HD). There are conflicting reports of disproportionate impairments for some emotions in some modalities in HD.
Introduction
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded CAG repeat on chromosome 4. It is classically characterised by involuntary movements and cognitive and psychiatric deficits, with the onset of motor signs usually occurring in mid-adulthood. There is, however, often evidence for subtle cognitive and behavioural deficits ahead of these motor features (Lawrence et al., 1998; .
The ability to recognise emotions in others is a key social skill, and much work has focused on studying the expression and recognition of canonical emotions (happiness, sadness, fear, surprise, anger and disgust) which appear to be cross-cultural, and which it is argued have a biological basis (Ekman, 1992 (Ekman, , 1993 . More recently, attempts have been made to elucidate the neural substrates of emotion recognition, with lesion studies and functional brain imaging providing new insights into the pathways underlying this skill (e.g., Calder et al., 2004; Phillips et al., 1998; Scott et al., 1997) ; for a review see Adolphs (2002) .
Over the last two decades there has been increasing interest in emotion recognition deficits in people with HD, and this interest is justified on both clinical and neurobiological grounds. HD is relatively common (Harper, 2002; Novak and Tabrizi, 2010) and has the potential for presymptomatic diagnosis (and therefore early intervention with disease-modifying therapies). These factors lend particular urgency to the search for biomarkers of brain dysfunction in HD, and emotion recognition is a promising candidate Stout et al., 2011; Tabrizi et al., 2009 ). In addition, HD has contributed to the literature on models of emotion recognition, as associations are made between the behavioural deficits seen in the disease, and the affected brain regions.
An initial finding of disproportionately impaired recognition of facial expressions of disgust was found in people with early symptoms of the disease (Sprengelmeyer et al., 1996) . This was followed by suggestions that facial disgust recognition might also be affected in premanifest gene carriers (Gray et al., 1997) , and that recognition of disgust in other modalities, such as voices, taste and odours (Hayes et al., 2007; Mitchell et al., 2005) , was also impaired. However other work has failed to replicate the disproportionate impairment in disgust recognition, instead suggesting that recognition of all negative emotions is broadly affected in HD (Henley et al., 2008; Johnson et al., 2007; Milders et al., 2003) . The aim of this review was therefore to disambiguate the pattern of emotion recognition deficits in HD through a systematic appraisal of previous reports.
This review is warranted to better understand the nature and progression of cognitive impairment in HD, and how it might impact on people with HD and their carers. A better conceptualisation of the emotion recognition deficits in HD is important to improve understanding of the social interaction problems that occur in the disease. From this, more refined strategies for managing these problems might be developed. More fundamentally, the emotion processing deficit in HD and its brain mechanism may hold important clues to the pathophysiology of the disease. In particular, a selective deficit of emotion comprehension would (if substantiated) potentially predict a relatively specific pathophysiological and anatomical substrate which could in turn targeted as a biomarker of disease modification in future therapeutic trials (Henley et al., 2005; Tabrizi et al., 2009) .
The purpose of this review was to appraise systematically the reported impairments in emotion recognition in HD. Such a review is warranted in order to assess the nature of the deficits reported, and to investigate whether differences in findings can be explained by disease-related factors, such as stage or CAG repeat length. The review aims to ask what conclusions can be drawn from the current literature about which emotions people with HD struggle to recognise, and in which modalities, as well as to identify areas for future research.
Methods
2.1. Criteria for considering studies for this review 2.1.1. Types of studies In order to be eligible for inclusion in the review studies had to compare emotion recognition in a group of participants with Huntington's disease with a control group (i.e., quasi-experimental design). Emotion recognition was defined as any task in which stimuli conveying emotional information were presented, and for which participants were asked to state or choose which emotion they thought was represented by the stimuli. The stimulus could be of any modality (e.g. visual, vocal) and of any form (e.g. static faces, videos). Any target emotions were considered. Studies in which participants were asked to match emotions within a modality were excluded (e.g. selecting a happy face in response to a happy face stimulus); success on this task might be achieved using perceptual features alone. Studies in which participants were asked to match emotions across a modality (e.g. selecting an angry face in response to an angry voice) were included as this cannot be solved purely on the basis of the perceptual features of the stimuli.
Studies looking exclusively at "mood" or emotion production, or semantic knowledge (e.g. about situations that might be expected to induce emotions) were excluded. Editorials, reviews, commentaries, letters or other articles that contained no original data were excluded.
Types of participants
The patient group had to consist of participants carrying the gene coding for Huntington's disease (Huntington's Disease Collaborative Research Group, 1993) , confirmed by genetic analysis. This excluded any studies done before genetic testing was available, but ensured that findings were specific to this population.
Studies of both manifest (showing hard motor signs of HD) and premanifest (not yet showing hard motor signs of HD) participants were included. Manifest HD is conventionally defined as the point at which gene carriers develop hard motor signs. Clinically, this can be a useful way in which to define disease onset, although in practice more subtle motor, cognitive and behavioural deficits are usually present many years before this point (Huntington Study Group, 1996; . The control group had to be neurologically normal participants. Studies of any participants aged 18 or over were included. Participants with onset prior to this age are likely to have very high CAG repeat lengths and a rapidly progressing disease process as well as immature emotion processing mechanisms, which may be qualitatively dissimilar to those in adults (Gao and Maurer, 2010; Kremer, 2002, pp. 43-44) .
Types of measures
Studies must have reported a quantitative measure of emotion recognition.
Search methods for identification of studies

Electronic searches
Searches were run in the following databases: Embase (1993-July 2010), MEDLINE (1993 -July 2010 , PsychINFO (1993 -July 2010 and PubMed (1993 -July 2010 .
Searches were limited from 1993 to the present day, as studies carried out prior to this would necessarily have included participants without genetically-confirmed HD.
The search used keywords "(Huntington* AND (emotion* OR cogniti* OR neuropsycho*)) NOT (mouse OR rat OR mice)". Using Ovid the search was run on Embase, MEDLINE and PsychINFO simultaneously and results were then deduplicated (a function within Ovid).
Only peer-reviewed published articles were accepted for inclusion in the review. Attempts were made to contact corresponding authors of all articles included in the review, either to ask for access to more demographic or experimental data, or to check queries about the study.
Searching other resources
For each study included in the review, manual searches of reference lists were conducted and a citation search was also conducted to identify further potential studies.
Data collection and analysis
Selection of studies
The initial searches identified 1724 citations (after deduplication). The title and abstract of each citation were examined independently by both SMDH and MJUN against the pre-specified inclusion and exclusion criteria listed above.
104 citations could not be excluded on the basis of the title and abstract alone (a proportion of these did not have an abstract available). The full text of these citations was obtained by SMDH to assess whether they fully met inclusion criteria. One additional citation was identified from the reference list and citation search.
Data extraction and management
Data were extracted to a standardised data collection form. This covered demographic information, details of emotion recognition tests, any background tests, results, and technical assessment.
Technical assessment
Study structure and technical characteristics were assessed according to a number of criteria: sample size and power analysis; the nature of the control group; reporting of demographic data, the nature of stimuli, stimulus presentation and response options; ways in which potential confounding variables were measured and addressed; appropriate statistics; and reporting of quantitative outcome data. Demographic data considered necessary in order to be able to compare groups adequately between studies were: age, gender, some measure of estimated IQ or educational level, and additionally in the gene-positive group, CAG repeat length, and some estimate of disease course e.g. disease duration, UHDRS motor score or an estimate of time to motor onset in premanifest subjects (e.g., Langbehn et al., 2004) . (Note that these demographic data were considered desirable in order to assess studies fully, but these were not criteria for inclusion in the review overall.)
Data synthesis
Given that the data reviewed here were quantitative a metaanalytic approach was considered. Ultimately, however, a narrative synthesis was undertaken for two reasons. Firstly, although attempts were made to contact representatives of all the studies included in the review, some authors could not be contacted and this meant that quantitative results were not available for all studies. Secondly, the ways in which the HD cohorts varied between studies were not always clear (e.g. measures such as IQ, CAG repeat length, disease severity and duration were not always reported). This meant that it would not be possible to determine the extent to which differences in effect size were attributable to differences in these factors between the cohorts studied.
Results
Description of studies
Results of the search
Sixteen reports met full inclusion criteria. Appendix A summarises reasons for which 89 studies that met initial inclusion criteria were excluded after the full text was examined. Of the sixteen studies included, one or more individual experiments from five of them were subsequently excluded for not meeting criteria (see Appendix B).
Included studies
See Table 1 for characteristics of included studies.
3.1.2.1. Studies of facial emotion recognition. The majority of studies (14/16) included at least one test of facial emotion recognition (exceptions were Hayes et al. (2007) and Mitchell et al. (2005) ). The two most commonly used face stimulus sets were 60 (or 24) static black and white images from the Ekman and Friesen battery (Ekman and Friesen, 1976) , 10 (or four) each for happiness, sadness, surprise, disgust, anger and fear, henceforth "Ekman Faces"; and the set of 30 face images 1 morphing between these six canonical emotions from the FEEST (Young et al., 2002) . In this latter test, the "Emotion hexagon", presentation of the 30 face stimuli is repeated over six blocks, with results from the first block subsequently discarded as practice trials. Three studies also included neutral face stimuli in at least one test Snowden et al., 2008; Tabrizi et al., 2009) . Two studies used the same brief (24-stimulus) version of Ekman Faces (Gray et al., 1997; Henley et al., 2008) . Some researchers opted to replace or supplement these tests with their own stimuli in a similar format (e.g., Aviezer et al., 2009; Snowden et al., 2008) . One study used colour video clips made by morphing between neutral and emotional still photographs (Montagne et al., 2006) .
One study also included a test of emotion recognition from eye regions only (Snowden et al., 2008) .
Studies of auditory emotion recognition.
Five studies included tests of emotion recognition in the auditory modality, testing either short non-verbal vocal sounds (e.g. laughter, growls) or prosody of spoken phrases constructed from non-words. Three of these studies (Calder et al., 2010; Snowden et al., 2008; Sprengelmeyer et al., 2006) used stimuli taken from the same set of non-verbal vocal sounds (Scott et al., 1997) . One study used their own non-verbal stimuli (Hayes et al., 2007) , and two studies used the same "nonsense" word prosody recognition task (Sprengelmeyer et al., 1996 (Sprengelmeyer et al., , 2006 .
Studies of emotion recognition in other modalities.
One study included a test of emotion recognition of static black and white pictures portraying body language (Aviezer et al., 2009 ) and one, looking specifically at disgust recognition, tested recognition of pleasant and disgusting tastes and odours (Mitchell et al., 2005) .
Response options.
All the studies, with the exception of Mitchell et al. (2005) (investigating taste and odour perception) used a forced choice response paradigm, in which participants were given a limited set of written verbal emotion terms and asked to pick the one that best described the stimulus.
3.1.2.5. Study populations. Eight studies included a sample of premanifest HD gene carriers, and 10 included a sample of people with manifest HD (i.e., unequivocal motor signs). One study included both premanifest and manifest participants in the patient group (Aviezer et al., 2009) .
Study populations were drawn from a range of countries, including the United Kingdom (7), Australia (4), Germany (3), Canada (3), The Netherlands (2), France (1) and the United States (1). Ethnicities of participants in each country were not reported in any study. Culturally, this is a relatively restricted sample, based almost entirely on Western/European (the majority English-speaking) countries.
Assessment of methodological factors
Study methodology was assessed in four distinct categories: choice of control group; reporting of key demographic data and results; stimulus type, presentation and response options; and reporting of statistical analysis, including discussion of power, potential confounding variables and the issue of multiple comparisons (Table 2) .
Reporting of key demographic data and results
Huntington's disease is highly heterogeneous, and clinical presentation is known to depend on age and CAG repeat length (and their interaction); these explain some of the variance in age of motor onset (see e.g., Mahant et al., 2003; Rosenblatt et al., 2006) . It is therefore important to be able to rule out differences in the clinical characteristics of cohorts as a potential cause of differences between study findings. In addition, factors such as age, education and intelligence, and possibly gender, may affect performance on cognitive tasks in both HD and control groups. The impact of these factors both within studies (between patient and control groups) and between studies needs to be taken into account when assessing differences in outcome. Consequently it is important for studies to report summary data for each of these variables, so that the effects (if any) of these potential confounders can be judged.
Four studies were considered to have reported adequate demographic data: age, gender, an index of intellectual ability, CAG repeat length, and an index of disease severity (Henley et al., 2008; Hennenlotter et al., 2004; Sprengelmeyer et al., 1996 Sprengelmeyer et al., , 2006 . Most others reported most of the above variables but many did not have CAG repeat data available; in these cases although participants had undergone genetic testing for confirmation of diagnosis, researchers had not always requested (or been granted access to) the exact CAG data. Some lacked an estimate of intelligence or educational level, although some authors were able to provide the extra data on request.
Also of note is the fact that studies varied in their definition of pathological CAG repeat length. Typically alleles of up to 35 repeats are considered normal, whilst alleles with 40 or more repeats are fully penetrant and the carrier is likely to show signs of HD within a normal lifespan. The intermediate repeat numbers (36) (37) (38) (39) are not fully penetrant but there have been reports of 36 CAG repeats leading to the disease, and of people living into their 90s with 39 CAG repeats and no signs of HD (Rubinsztein et al., 1996) . Whilst the majority of studies tend to include participants with a CAG repeat length of 40 or above, at least two included participants with CAG repeat lengths between 36 and 39 (Aviezer et al., 2009; Tabrizi et al., 2009) , and not all report their criteria. This raises the possibility that some participants may not be representative of the more general HD population.
The majority of studies reported their findings in full (i.e., gave quantitative measures of central tendency and spread in each of the groups tested). A number of authors made their raw data available on request if they were not available in the published paper. Some authors preferred to report composite scores (Sprengelmeyer et al., 2006; Tabrizi et al., 2009) , and were able to justify this, although this makes it difficult to draw direct comparisons between individual tests.
Choice of control group
Control groups were of three different kinds. Ten studies used healthy volunteers as controls; five used gene-negative controls from an HD environment (either people who had been at risk and tested negative for the HD gene, or partners of gene-positive participants); and one study used at-risk gene-negative controls who were unaware of their negative gene status when they completed the study tests. The rationale for using gene-negative or partner controls is that these people live in a similar social and emotional environment to people with HD; interacting with family members whose emotion recognition, and possibly expression, is impaired may impact on the controls' expression and recognition of emotion, and they are more likely than unrelated volunteers to be subject to similar stresses, and therefore have similar levels of anxiety and depression. In support of this, gene-negative controls in some studies have been shown to perform below "healthy" control level at facial emotion recognition (Gray et al., 1997; Henley et al., 2008; Sprengelmeyer et al., 2006) . Use of a gene-negative control group therefore aims to minimise group differences attributable to social or emotional factors.
Stimulus type, presentation and response options
As mentioned above, the majority of studies used very similar stimulus sets. Facial stimuli were usually based on the Ekman and Friesen set (Ekman and Friesen, 1976) . However there are a number of variations of this: whether simple faces or the Emotion Hexagon are used, whether or not neutral faces are included, and the overall number of stimuli used. Only two studies included nonEkman facial stimuli, one using a similar black and white static set (Snowden et al., 2008) and one making their own colour videos from actors (Montagne et al., 2006) .
Similarly, studies of vocal emotion recognition tended to use stimuli drawn from the same set (either a set of non-verbal vocal sounds, see Scott et al. (1997) , Calder et al. (2004) , or the prosodic stimuli used by Sprengelmeyer et al. (1996) ). One exception was Hayes et al. (2007) where it seems that novel non-verbal vocal stimuli were used.
There were a number of subtle variations of presentation and response options, particularly pertinent to facial stimuli as these are not naturally time-limited (as auditory stimuli are). Some faces were presented for a limited time, others were presented until participants had made a choice. As mentioned above, in the Emotion Hexagon test each stimulus is repeated six times (responses from the first presentation being discarded as practice items), whereas in simple face tests each stimulus is presented only once.
Most studies did not impose a fixed time to respond, but two limited the time available in which a response could be made Tabrizi et al., 2009 ). All studies of facial and vocal emotion recognition used an alternative forced choice (AFC) response paradigm, but they varied in the choices given. Most gave the same number of response options as there were emotion categories (e.g. if six different emotions were presented, there would be six response options). One deliberately reduced the number of responses (Snowden et al., 2008) in order to evaluate performance when task demands were decreased. One study used a 6AFC response when only four different emotions were represented in the stimuli (Aviezer et al., 2009 ).
Statistical analysis 3.2.4.1. Power analysis and sample size.
Only two studies reported considerations of power and sample size calculation Tabrizi et al., 2009 ). These were the two largest studies (over 100 participants in the patient groups), and both had calculated that they were adequately powered to detect relatively small effects in premanifest and manifest HD populations. Sample sizes in the remaining studies ranged from six (Mitchell et al., 2005 , odour test) to 40 (Henley et al., 2008) .
Potential confounding variables.
Potential confounding variables were dealt with in a number of different ways. Almost all studies reported gender, age and some measure of estimated premorbid intelligence or educational level. Most of these reported that groups were "matched" for one or more of these variables, and some, but not all, reported a statistic to confirm that there were no statistically significant differences between groups. Four studies included some or all of these variables as covariates in their analysis (Henley et al., 2008; Johnson et al., 2007; Milders et al., 2003; Tabrizi et al., 2009) .
Almost all studies that tested facial emotion recognition included a standard test of face recognition 2 and sometimes a test of visual acuity or contrast sensitivity, and other visual or face processing tasks (the exception was Tabrizi et al. (2009) , which was designed to assess potential biomarkers, rather than to test facial emotion recognition per se). One study excluded two participants with poor acuity (Aviezer et al., 2009) , and no other studies reported impairments in basic visual skills. Six studies reported that performance on the Benton Facial Recognition Test was significantly worse in HD groups than control groups. Two took this into account in their analysis: one adjusted for facial recognition ability by including Benton score as a covariate in the analysis (Henley et al., 2008) and one investigated whether Benton scores correlated with emotion recognition scores (Snowden et al., 2008) . The others did not take poor Benton performance into account in the emotion recognition analysis although mean (SD) Benton data in most cases = discussed, and stats adapted accordingly; = stats adjusted for inhomogeneity of variance only;
= not discussed. Multiple comparisons addressed: = discussed and addressed; = not discussed. Confounders measured and controlled for:
= effect of potentially confounding variables taken into account in analysis; = effect of some potentially confounding variables taken into account in analysis; = not considered.
suggest that some participants may have been fallen into the "moderately impaired" range. In two studies in which a group difference was not found on the Benton, some HD participants still scored in the "moderate impairment" or "severe impairment" range although this is not commented on (Aviezer et al., 2009; Gray et al., 1997) . In addition to those studies that reported group differences in Benton score, one study included Benton as a covariate in the main analyses although did not report whether group differences were statistically significant .
Studies that included auditory stimuli did not report testing auditory perception. The one study that investigated taste and olfactory recognition tested olfactory identification and threshold and excluded two HD participants from the olfactory experiment on the basis of poor performance (Mitchell et al., 2005) .
Overall, potential confounding variables were not always dealt with satisfactorily. Very few studies adjusted for demographic variables despite the fact that non-statistically significant betweengroup differences in demographic variables can still materially impact on between-group differences in other variables . Additionally, in some cases it seems likely that poor facial recognition skills in one or two HD participants may have impacted on the emotion recognition scores for the group as a whole.
3.2.4.3. Normality of data. The majority of studies noted that data did not meet assumptions needed for parametric statistics. Many cited ceiling effects and used non-parametric tests (e.g. techniques such as Mann-Whitney tests, or using bootstrap confidence intervals), whilst some just acknowledged heterogeneity of residual variance between groups and used appropriate statistics for this.
Five studies used parametric statistics and did not discuss whether the data were normally distributed (Aviezer et al., 2009; Hayes et al., 2007; Milders et al., 2003; Mitchell et al., 2005; Montagne et al., 2006) . One study used non-parametric statistics for behavioural data, but opted to use parametric statistics for analysis of untransformed mean reaction time data, although it would seem likely that such data might have been positively skewed (Sprengelmeyer et al., 2006) .
Multiple statistical comparisons.
All studies reported several statistical comparisons. Three studies reported Bonferronicorrected results (controlling the false positive rate across a number of comparisons) (Calder et al., 2010; Hayes et al., 2007; Milders et al., 2003) . Three studies discussed the increased risk of false positives but preferred to maximise power by reporting uncorrected results (Henley et al., 2008; Snowden et al., 2008; Sprengelmeyer et al., 2006) . The remaining ten studies did not discuss this issue.
3.2.4.5. Reporting of analysis and results. The majority of studies reported their analysis and test results clearly. Most studies reported two-tailed tests. Four studies chose to use one-tailed tests for some or all of their comparisons based on a priori predictions that the HD group would, on average, do worse than controls (Gray et al., 1997; Hennenlotter et al., 2004; Kipps et al., 2007; Sprengelmeyer et al., 2006) although Sprengelmeyer et al. (2006) still report one test in which the HD group outperformed the control group.
Outcomes
Outcomes are described separately for manifest and premanifest populations as this is how the majority of studies were designed. As discussed above, this is a somewhat arbitrary distinction, based on an assessment of motor symptoms. There is inevitably variation between clinicians with regard to when symptoms are judged sufficient to make a diagnosis of manifest disease, and different studies use different cut-off points to define this. Aviezer et al. (2009) included both manifest and premanifest participants in a single group in their study. Examination of their data shows that nine out of 21 participants who completed the study had a UHDRS motor score of five or less, a cut-off used elsewhere to discriminate between manifest and premanifest participants (Tabrizi et al., 2009) . Therefore since the majority of participants had clear signs of the disease, Aviezer et al.'s results are reported below as representing manifest HD.
Outcomes are described as statistically significant if they were reported as such in the original study. The majority of studies set p < 0.05 as the cut-off for statistical significance. As reported above, studies varied as to whether or not they adjusted this cutoff for multiple comparisons. Therefore in studies that opted to use a Bonferroni-type correction larger effect sizes will have been required in order for a result to be reported as statistically significant, relative to studies that did not opt to use this correction.
Facial emotion recognition
In participants with manifest HD the most consistent evidence of impairment was shown for recognition of facial anger: statistically significant effects were found in every study that included a test for it. Evidence of disgust recognition impairment was also found in almost every study that tested it. The only exception was Snowden et al. (2008) in a task in which they gave a two-alternative forced choice response option to the Ekman faces, instead of the usual six (i.e., they reduced task demands); anger and fear recognition were still impaired in this condition. Evidence that fear recognition was impaired was often found, although only using Ekman stimuli (not moving facial stimuli (Montagne et al., 2006) , or a nonEkman stimulus set, the "Manchester" set, a different, locally-made set of black-and-white static emotion faces (see Snowden et al., 2008) ). Sadness and surprise recognition were found to be impaired less often, whilst a statistically significant impairment in happiness recognition was only found by two groups (Calder et al., 2010; Hayes et al., 2009) (Table 3) .
In premanifest participants a statistically significant impairment in disgust recognition was most frequently reported and was seen in five out of eight studies. Three of these reported evidence that disgust was selectively impaired (Gray et al., 1997; Hennenlotter et al., 2004; Sprengelmeyer et al., 2006) , whilst two found an impairment across negative emotions Tabrizi et al., 2009 ). Sprengelmeyer et al. (2006) also reported evidence of a deficit in surprise recognition at the third of three timepoints tested. The remaining three studies found no evidence of impairment at all in premanifest participants, although one study explained a finding of impaired happiness recognition as an artefact of the ceiling effect in controls for that emotion (Henley et al., 2008) . Snowden et al. (2008) found evidence that manifest HD participants were impaired at recognising sadness and disgust from the eye regions alone (Table 3) .
Vocal emotion recognition
In manifest participants evidence of an impairment in vocal disgust recognition was found consistently (four out of four studies) for both short non-verbal vocal sounds and speech prosody. Anger recognition was found to be statistically significantly impaired in the three studies using non-verbal vocal sounds, but not for prosody. Evidence of an impairment in fear recognition was also found in three out of four studies, including both non-verbal vocal sounds and prosody. Using prosodic stimuli, statistically significant impairments were also reported for recognising surprise and happiness (Sprengelmeyer et al., 1996) although no other studies reported evidence of deficits in these emotions. No studies reported statistically significant impairments in recognising sadness from vocal sounds (Table 4 ).
Only one study tested vocal emotion recognition in a premanifest cohort (Sprengelmeyer et al., 2006) and reported no evidence of impairments at any of three timepoints tested, using a combined score from sounds and prosodic stimuli (Table 4) . Aviezer et al. (2009) found no evidence that their HD population was impaired at recognising sad, disgusted or angry body language. Some of the body language stimuli contained semantic clues (dirty underwear for disgust, and a gravestone for sadness). It is possible that people with HD were able to label the images based Calder et al. (2010) Ekman faces on previously acquired semantic knowledge, rather than recognition of the emotion conveyed by the body postures of the models. Mitchell et al. (2005) reported that their manifest HD cohort tended to rate unpleasant odours and taste combinations as less disgusting than controls, and that this difference was statistically significant. However this study differed from those for the facial and vocal modalities in using subjective ratings, rather than categorisation of an objective stimulus; mean ratings suggest that participants with HD were still able to discriminate between pleasant and less pleasant stimuli, which makes it hard to draw inferences about more specific recognition impairments in this paradigm (Table 5 ).
Recognition of emotion in other modalities
᭹ ᭹ ᭹ ᭹ ᭹ ᭹ Emotion hexagon ᭹ ᭹ ᭹ ᭹ ᭹ ᭹
Cross-modal comparisons
Several studies included tests of emotion recognition in more than one modality, although they only report independent statistics for group differences in each modality (i.e., they do not directly statistically compare performance between modalities). Aviezer et al. (2009) reported that anger and disgust recognition from Ekman faces was statistically significantly impaired in the absence of impairments in recognising emotional body language. Calder et al. (2010) found evidence of a global impairment in recognising the six canonical emotions from Ekman faces, but evidence that only disgust, anger and fear recognition were impaired from non-verbal vocal sounds. A similar pattern was shown by Snowden et al. (2008) using the same face stimuli: recognition of all emotions except happiness was statistically significantly impaired with facial stimuli, whilst only disgust, anger and fear were impaired with non-verbal vocal sounds. However using a different set of faces Snowden et al. (2008) reported evidence of impairment only for disgust and anger recognition. In the study of Sprengelmeyer et al. (1996) subjects showed evidence of impaired recognition of surprise, disgust and fear from both facial expressions and prosody, but impaired sadness and anger recognition only from facial expressions. In a premanifest cohort, evidence of a selective impairment recognising the facial expression of disgust was found in the absence of impairments for the other five canonical facial emotions, or any deficits in recognising emotions from sounds or prosody (Sprengelmeyer et al., 2006) .
Disproportionate deficits in recognition of specific emotions
Early reports suggested that HD gene carriers (both manifest and premanifest) were disproportionately impaired at recognising disgust, both using faces and prosody (Gray et al., 1997; Sprengelmeyer et al., 1996) . Sprengelmeyer et al. (1996) tested this statistically, expressing manifest HD scores as a proportion of the mean score in controls (to adjust for emotion difficulty) Snowden et al. (2008) Non-verbal vocal sounds Sprengelmeyer et al. (1996) Prosody ᭹ ᭹ ᭹ ᭹ Premanifest HD Sprengelmeyer et al. (2006) Prosody + non-verbal vocal sounds
Key: Ha = happiness; Sa = sadness; Su = surprise; Di = disgust; An = anger; Fe = fear; Ne = neutral. ᭹ = between-group difference; = no between-group difference; blank = not tested. Key: Ha = happiness; Sa = sadness; Su = surprise; Di = disgust; An = anger; Fe = fear; Ne = neutral. ᭹ = between-group difference; = no between-group difference; blank = not tested.
and comparing disgust recognition with the next worst recognised emotion, fear. Disgust recognition was statistically significantly worse than fear recognition for Ekman Faces, Emotion Hexagon, and prosodic stimuli; HD participants scored at or below chance level. Sprengelmeyer et al. (2006) also report that in a premanifest cohort facial disgust recognition was the only emotion to be statistically significantly impaired relative to controls, and that 5/12 gene carriers were only impaired (judged by z scores) at disgust, whilst the other seven participants were either unimpaired, or globally impaired. Three other studies report selective or disproportionate impairments in disgust recognition. Gray et al. (1997) and Hennenlotter et al. (2004) both found evidence that facial disgust recognition was the only emotion impaired in premanifest cohorts, although this was not assessed statistically in relation to other emotions. Hayes et al. (2007) reported that more HD participants had z scores of >−1.56 (and more scored at levels judged consistent with chance) for non-verbal vocal disgust recognition than for any other vocal emotion, although again, differences between emotions were not assessed statistically. Most other studies do not report selective or disproportionate impairments in disgust recognition. Hayes et al. (2009) tested differences between emotions and found no evidence that one was more impaired than any other (Ekman Faces and Emotion Hexagon). Henley et al. (2008) compared emotion recognition performance statistically (adjusting for control scores) and found recognition of anger to be disproportionately impaired (Ekman Faces) . Milders et al. (2003) found evidence that recognition of disgust was less impaired than recognition of anger, fear and sadness (Ekman Faces) . Snowden et al. (2008) reported either no evidence of impairment of disgust recognition (Ekman Faces with 2AFC), or that no patient got their worst scores at disgust recognition (Ekman Faces with 6AFC); when assessed statistically, disgust recognition in their HD group was no worse (and in one case was better) than fear and anger recognition both for the Manchester faces and eyes set (see Section 3.3.1), and for non-verbal vocal sounds. Other studies did not test inter-emotion differences statistically but argued that the pattern of findings did not support a disproportionate impairment of disgust recognition (e.g., Aviezer et al., 2009; Calder et al., 2010 , who found a greater number of HD participants impaired at anger across all tasks; Johnson et al., 2007; Montagne et al., 2006) .
Within-modality stimulus type comparisons
Many studies used both the "Ekman Faces" set, as well as the "Emotion Hexagon". Calder et al. (2010) reported similar deficits (across all emotions except happiness) with both stimulus sets. Hayes et al. (2009) found evidence that sadness, surprise, disgust, anger and fear recognition were impaired using both the Emotion Hexagon, and Ekman Faces at varying intensities, although happiness was only impaired on the Ekman Faces set, and no impairment was seen for 25% and 50% sad Ekman Faces. Snowden et al. (2008) compared the Ekman Faces set 6AFC, with 2AFC, an alternative face set, and eye regions only. They reported a statistically significant recognition deficit across all emotions except happiness using Ekman Faces, reduced to anger and fear recognition deficits when the task was simplified (2AFC), whilst only disgust and anger recognition were impaired on the alternative "Manchester" set, and sadness and disgust recognition using eye regions only.
Summary
Disgust, anger and fear recognition were most often impaired in manifest HD populations, across modalities. For face recognition, the most frequently tested modality with the most consistency in stimulus presentation, a deficit in anger recognition was found in all the studies in which it was tested. In premanifest populations deficits are more commonly seen for disgust recognition than any other emotion, but only in the facial modality. Whilst disgust recognition appears disproportionately impaired in some HD populations, this is not true of all populations tested, nor across modalities. Outcome varies depending on the type of stimulus used (even within a modality).
Discussion
Certain general conclusions emerge from this review of studies of emotion recognition in HD. Considering firstly the most widely used emotional stimulus (facial expressions), anger recognition appears to be most consistently impaired in manifest HD populations, closely followed by recognition of disgust and fear, whereas recognition of sadness and surprise are less consistently affected, and recognition of happiness only rarely affected. Individuals with pre-manifest HD may exhibit no detectable deficit; however, if there is an impairment of emotion recognition this is likely to affect disgust or recognition of negative facial emotions more generally. Deficits of facial emotion recognition become more likely, more severe and more widespread with the conversion from premanifest to manifest disease. However, the lack of uniformity in measures of disease stage and severity across studies precludes a precise statement about the time course or profile of these deficits; this is one of the biggest weaknesses in the literature. HD is known to be highly heterogeneous, and clearly this natural clinical variability may underlie many of the inter-study differences reported here, meaning that where differences do exist, they are not necessarily contradictory. Nevertheless, between-group differences in levels of potential confounds (e.g. CAG repeat length, or severity) may also underlie differences in behavioural findings, and until these confounds are reported consistently this will be impossible to judge.
In line with early work in the field, initial evidence suggested that that impaired recognition of facial expressions of disgust occurs early in HD (Gray et al., 1997; Hennenlotter et al., 2004; Sprengelmeyer et al., 2006) ; however, two large studies have suggested that this deficit may occur in the context of a more widespread impairment affecting negative emotions, even early in the course of premanifest stages of disease Tabrizi et al., 2009) . In manifest HD, most studies do not suggest a disproportionate defect of a particular emotion when recognition of different emotions is compared directly, though negative emotions are generally affected more severely than the positive/ambiguous emotions of happiness and surprise. Taken together the evidence suggests that recognition of various negative emotions may be affected from an early stage in HD, and that impairments worsen across emotions as disease evolves.
Information about recognition of emotions via other sensory channels in HD remains too limited for firm conclusions to be drawn. However, at least for vocal emotion recognition, the picture emerging is broadly convergent with the data for facial expressions. In studies of manifest HD recognition of vocal disgust is consistently impaired, although recognition of vocal anger and fear are often also impaired. Evidence concerning the relative degree of impairment for particular vocal emotions is conflicting (Calder et al., 2010; Hayes et al., 2007; Snowden et al., 2008; Sprengelmeyer et al., 1996) . The few data available for premanifest HD have not provided evidence of an early deficit of vocal emotion recognition. This pattern suggests that, as for facial expression, impaired recognition of vocal expressions in HD may become more salient with evolving disease and may be more marked for negative than for positive emotions. It is likely that there are modality-specific factors here: for example, the apparent preservation of recognition of vocal (in contrast to facial) expressions of sadness may mean that sadness is intrinsically easier to recognise from auditory than from visual cues (Rohrer et al., 2010) or that different sensory modalities are differentially affected in HD. However, inter-modality differences have yet to be evaluated statistically.
These findings have important clinical implications. One key implication is that emotion recognition could potentially serve as a biomarker of disease onset and progression in HD. Emotion scores (both composites and individual emotions) are already included in the two largest ongoing longitudinal studies, PREDICT-HD and Track-HD (Tabrizi et al., 2009) and further work should demonstrate how sensitive emotion recognition is at tracking decline over time, relative to other potential markers.
From the perspective of the individual patient with HD, these results clearly show that manifest HD is associated with impaired recognition of negative emotions. Furthermore, subtle impairments of emotion processing can be detected many years before motor onset. There is little formal evidence concerning the impact of emotional deficits on the social functioning of people with HD. However, the results of this analysis suggest the potential for some compensation if multiple (especially non-facial) channels can be used to convey emotional information to people with HD.
There are important limitations on an analysis of this kind. The review was limited to peer-reviewed publications: an important potential source of bias in attempting to estimate the overall significance of emotion recognition deficits in HD. In addition, the size and comprehensiveness of the studies included in the review varied widely. Small studies are potentially under-powered to detect small effects or to adjust for confounding factors (particularly for non-standard data distributions), whilst in large studies it may be more difficult to tailor assessments to particular kinds of deficits or to assess deficits comprehensively. A further source of variation between studies is linked to the different paradigms used to assess emotion recognition, even within a modality (e.g., facial expressions); using different stimulus sets does lead to divergent findings (Snowden et al., 2008) and our understanding of emotion processing mechanisms remains too rudimentary to offer a principled account of this.
This review suggests certain clear directions for further work. There is a need for large, longitudinal studies of emotion comprehension in HD that are informed by emerging neurobiological data and which use consistent measures of disease stage and overall severity as well as uniform assessment instruments. In future studies it will be important to compare emotion processing in different sensory modalities statistically, and at different levels of response (autonomic as well as cognitive); and to extend the assessment to include more ecological kinds of emotion processing beyond the relatively artificial scenario of the forced-choice recognition protocol. There is also a need to understand how these deficits, and the other cognitive difficulties noted in this disease, impact on patients' everyday lives. The data that are currently available suggest that there is no 'magic bullet' of selective emotional impairment that is specific or selective for HD. On the other hand, the data provide grounds for some optimism that emotion comprehension is a useful paradigm of disease onset and progression in HD. Like other diseases, HD will almost certainly benefit from the exciting progress currently being made in the basic neuroscience of human emotion. However, the study of patients with HD could also inform this enterprise, and the structural and functional anatomical bases for altered emotion processing in HD should be addressed in hypothesis-led studies motivated by the neuropsychological data. As neuropsychological metrics of clear relevance to patients' everyday lives, there is an overarching need further to evaluate emotion processing measures as potential biomarkers for symptomatic and disease-modifying therapies in this devastating disease.
